The Advisors' Inner Circle Fund III Strategas Macro Thematic Opportunities ETF (ARCA: SAMT)

Latest news for The Advisors' Inner Circle Fund III Strategas Macro Thematic Opportunities ETF (ARCA:SAMT)

Technology

Energy

Industrials

Healthcare

Consumer Cyclical

Consumer Defensive

Financial Services

Other

The Fund is an actively-managed exchange-traded fund (ETF) that seeks to achieve its objective by investing principally in common stocks of U.S. companies that Strategas Asset Management, LLC (the Adviser) believes most highly correlate to macro-thematic trends. Macro is a top-down analysis approach in investing that focuses on the inputs that are generally out of a companys control, such as the overall economy, government fiscal and monetary policy changes, cultural and socioeconomic developments or trends, and developments arising from global crises including pandemics, wars, or financial distress. Thematic refers to the theses, trends or views that the Adviser believes are prevalent or likely to be prevalent in the market

Costco Wholesale Corp.

Eli Lilly Co

Nvidia Corp.

Meta Platforms, Inc.

Microsoft Corp

Broadcom Inc

Cencora Inc

Murphy Usa Inc

Applied Materials Inc

General Dynamics Corporation

Strategas Macro Thematic Opportunities ETF

The Advisors' Inner Circle Fund III Strategas Macro Thematic Opportunities ETF

SAMTY HLDGS CO LTD by SAMTY HLDGS CO LTD.

SAMTY RSDNTIAL INVT CP by SAMTY RESIDENTIAL INVT CORP.

Western Alliance Bancorporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) posted upbeat quarterly results, after the <a href="https://www.benzinga.com/quote/WAL/earnings">closing bell on Thursday</a>.
Western Alliance reported quarterly earnings of $1.75 per share which beat the analyst consensus estimate of $1.71 per share. The company reported quarterly sales of $771.80 million which beat the analyst consensus estimate of $737.64 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
&#8220;Western Alliance delivered strong second quarter results featuring robust net interest income growth, gathering loan momentum, and sustained deposit generation,&#8221; said Kenneth A. Vecchione, President and Chief Executive Officer. &#8220;With balance sheet repositioning actions completed, our focus is rededicated to generating safe, sound risk-adjusted growth supported by an enhanced liquidity profile and sturdy capital base. We achieved net income of $193.6 million and earnings per share of $1.75 for the second quarter 2024, which resulted in a return on tangible common equity1 of 14.3%. Capital generation continued to improve as pre-provision net revenue grew 22% linked quarter annualized excluding the impact of the FDIC special assessment.. Tangible book value per share1 climbed 13.2% year-over-year to $48.79 with a CET1 ratio of 11.0%.&#8221;
Western Alliance shares gained 7.9% to close at $76.72 on Friday.
These analysts made changes to their price targets on Western Alliance following the announcement.
<ul>
<li>Piper Sandler analyst Matthew Clark maintained Western Alliance with an Overweight rating and raised the price target from $76 to $93.</li>
<li>Barclays analyst Jared Shaw maintained the stock with an Overweight rating, while increasing the price target from $86 to $92.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39881674/top-4-tech-stocks-that-may-explode-in-july">Top 4 Tech Stocks That May Explode In July</a></li>
</ul>

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

These Analysts Boost Their Forecasts On Western Alliance After Upbeat Earnings

Wells Fargo analyst Roger Read maintains Ovintiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) with a Equal-Weight and lowers the price target from $54 to $52.

Wells Fargo Maintains Equal-Weight on Ovintiv, Lowers Price Target to $52

Serve Robotics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) shares are trading higher Monday. The stock appears to be moving on continued momentum after Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) disclosed a <a href="https://www.benzinga.com/news/24/07/39860370/serve-robotics-stock-rises-after-nvidia-discloses-10-stake">stake in the company last week</a>. 
What Happened: Serve Robotics shares soared 187% on Friday after Nvidia revealed a 10% stake in the robotics company in a filing with the U.S. Securities and Exchange Commission last week. 
In a filing released late Thursday, Nvidia said it now owns 3,727,033 shares of Serve Robotics after it converted a&nbsp;promissory note from Serve Robotics into 1,050,129 shares of common stock in April.
Serve Robotics went public via reverse merger with Patricia Acquisition Corp. According to <a href="https://techcrunch.com/2023/08/10/uber-nvidia-backed-delivery-robot-startup-serve-robotics-to-go-public/?guccounter=1&amp;guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&amp;guce_referrer_sig=AQAAAGtcb64bIwGTyTkg369BaKjiIth_ncMWIuozwSS-NvlOkMJFOCGJWC8RdBpn8DuR7oeAY4tKMRUsT3QyuPztSCkfrNvplbEa-7wDNdxMtCzoW9nAEkjvKtP1RJ4YNoYlxYihRUCRPG3kBNYccP-vCqpxbhjkP-DlYPFCYt-7HwAC">TechCrunch</a>, Serve Robotics was initially started as the robotics division of Postmates. The autonomous sidewalk robots started delivering to Postmates customers in 2018, but when Uber acquired Postmates in 2020, the robotics division was spun out as Serve Robotics.
It&#8217;s worth noting that Serve Robotics appears to be getting a lot of attention from retail traders on Monday. It was trending across various social sites at the time of publication. 
Check This Out: <a href="https://www.benzinga.com/news/24/07/39881748/elon-musks-xai-flips-the-switch-on-100k-nvidia-h100-gpus-worth-up-to-4b-in-memphis-supercluster-most">Elon Musk&#8217;s xAI Flips The Switch On 100K Nvidia H100 GPUs Worth Up To $4B In Memphis Supercluster: &#8216;Most Powerful AI Training Cluster In The World&#8217;</a>
<h2 class="wp-block-heading">How To Buy SERV Stock</h2>
By now you're likely curious about how to participate in the market for Serve Robotics &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. 
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
SERV Price Action: Serve Robotics shares were up 47.8% at $11.16 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: courtesy of Serve Robotics.

Movers

NVDA

SERV

Serve Robotics Stock Is Soaring Again: What's Going On?

The global solar photovoltaic (PV) market was estimated at USD 150 billion in 2022 and is predicted to hit over USD 383.78 billion by 2032
Neve Yarak, Israel, July 22, 2024 (GLOBE NEWSWIRE) -- N2OFF, Inc.\ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NITO#NASDAQ">NITO</a>) (FSE:80W) ("N2OFF", or the "Company"), a clean- tech company offering sustainable solutions for various industries, announced today the expansion to the solar PV (photovoltaic) market, potentially proving investors lucrative assets alongside its innovation for the agri- tech market.
N2OFF partnered with Solterra Renewable Energy Ltd. ("Solterra"), a company founded in 2022 by Eran Litvak and Yair Harel, in the field of solar PV systems. Each of the founders is an expert in the field of solar PV, with a track record of dozens of successful projects. In addition, both are experienced entrepreneurs and managers with over 20 years of proven experience in identifying business opportunities, enhancing projects, and maximizing value in both the energy and financial sectors.
Solterra is currently active in three primary target markets: Italy, Poland, and Germany, managing a portfolio of at various stages of Solar PV development with a total cumulative capacity of approximately 300 megawatts.

NITO

N2OFF Signs An Agreement With Solterra Renewable Energy, Enters Solar PV Market

Plug Power Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares are trading higher Monday, bouncing back slightly after falling nearly 14% on Friday. Here&#8217;s a look at what <a href="https://www.benzinga.com/markets/equities/24/07/39858572/whats-going-on-with-plug-power-shares-today">you need to know</a>.
What To Know: Plug Power shares closed Friday down 13.9% after the company announced a $200 million <a href="https://www.benzinga.com/pressreleases/24/07/g39856913/plug-power-inc-announces-pricing-of-public-offering-of-common-stock">offering</a> of common stock. 
Plug Power said it will offer and sell 78,740,157 shares of its common stock at a public price of $2.54 per share. The company also granted its underwriters a 30-day option to purchase up to an additional 11,811,023 shares. The offering is expected to close on or about July 22. 
Plug said it anticipates gross proceeds of approximately $200 million. The net proceeds from the offering are expected to be used for general corporate purposes. 
On Monday, Piper Sandler analyst Kashy Harrison maintained Plug Power with an <a href="https://www.benzinga.com/analyst-stock-ratings">Underweight rating</a> and lowered the price target from $2.50 to $2.40.
Despite the bearish analyst coverage, Plug Power shares are moving higher, likely rebounding from heavy losses on Friday. Plug shares also appear to be getting a boost from upward momentum across broader markets. 
Check This Out: <a href="https://www.benzinga.com/government/24/07/39878618/whats-going-on-with-alibaba-and-other-chinese-stocks-on-monday">What&#8217;s Going On With Alibaba And Other Chinese Stocks On Monday?</a>
<h2 class="wp-block-heading">Is PLUG A Good Stock To Buy?</h2>
Wall Street analysts view Plug Power on the whole as an Underperform, given the history of coverage over the past three months. Jeffrey Osborne from TD Cowen is the most bearish, expecting a 28.57% fall in the stock in the coming year.
But looking at how the market as a whole thinks of the stock, you can reference historical price action for views on whether investors feel strongly about the stock one way or another. In the past three months, Plug Power fell 5.45%, which indicates that opinion soured on the business and how attractive it is to own based on either its stock price, or underlying fundamentals, like revenue, which fell 42.81% over the past year.
A complete overview of how Wall Street views individual stocks is available <a href="https://www.benzinga.com/analyst-stock-ratings">here</a>, while real time updates on the latest analyst actions will be delivered via <a href="https://pro.benzinga.com">Benzinga PRO</a>. Try it for free.
PLUG Price Action: Plug Power shares were up 3.77% at $2.61 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. 
Photo: courtesy of Plug Power.

PLUG

What's Going On With Plug Power Stock?

Tilray Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares are trading higher. The company on Monday announced that its cannabis cultivation facility in Germany received the first new cannabis cultivation license issued under <a href="https://www.benzinga.com/pressreleases/24/07/g39879382/tilray-receives-first-new-cannabis-cultivation-license-in-germany-under-new-regulations">Germany&#8217;s new Cannabis Act</a>.
What To Know: Tilray said Aphria RX GmbH received&nbsp;the first new cannabis cultivation license issued under MedCanG. The license will allow Tilray&#8217;s German facility to cultivate and manufacture a broad commercial range of medical cannabis.
&#8220;We are thrilled to receive this license as it will provide greater access to some of the highest quality medical cannabis produced in Germany and enable us to expand the range of treatment options available to patients,&#8221; said Denise Faltischek, chief strategy officer and head of international for Tilray. 
&#8220;We appreciate the trust that the German Government has placed in Tilray, and we are proud of our team for their groundbreaking work in medical cannabis cultivation and patient care.&#8221;
Tilray said it strongly believes these developments will have a positive impact on the health and well-being of many patients in Germany.&nbsp;The company noted that the introduction of the German cannabis bill has led to a significant increase in the number of patients and prescribers for medical cannabis.
Tilray is due to report <a href="https://www.benzinga.com/calendars/earnings">earnings for the fourth quarter</a> after the market close on July 29. 
See Also:<a href="https://www.benzinga.com/markets/cannabis/24/07/39874209/joe-biden-drops-out-what-would-happen-with-cannabis-legalization-under-kamala-harris-or-donald-t"> Joe Biden Drops Out: What Would Happen With Cannabis Legalization Under Kamala Harris Or Donald Trump?</a>
<h2 class="wp-block-heading">How To Buy TLRY Stock</h2>
By now you're likely curious about how to participate in the market for Tilray &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. In the case of Tilray , which is trading at $1.79 as of publishing time, $100 would buy you 55.87 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
TLRY Price Action: <a href="https://www.benzinga.com/quote/TLRY">Tilray shares</a> were up 3.35% at $1.85 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Anan Kaewkhammul/Shutterstock.

Cannabis

Global

TLRY

What's Going On With Tilray Brands Stock Monday?

The number of states where recreational weed is legal is growing each year. Top-selling states like California and Michigan have reported $2.1 billion and $1.6 billion, respectively, in recreational cannabis sales for the first half of 2024, as <a href="https://www.greenmarketreport.com/california-leads-the-industry-in-cannabis-sales-at-six-month-mark/">reported</a> by Green Market Report's Debra Borchardt.
California cannabis supremacy can't be argued even though many experts have insisted the state's <a href="https://www.benzinga.com/markets/cannabis/24/06/39195663/legal-california-cannabis-market-on-the-verge-of-collapse-while-illegal-growers-thrive-destroyin">marijuana market is &#8220;on the verge of collapse.&#8221; </a>On the other hand, the Golden State is home to the California State Fair at Cal Expo which just recently, for the first time in its 170-year history, allowed on-site cannabis <a href="https://www.benzinga.com/markets/cannabis/24/07/39782466/californias-first-cannabis-friendly-state-fair-with-on-site-sales-and-consumption">sales and consumption.</a>
Moreover, exciting news that Snoop Dogg is set to open his first licensed cannabis store, S.W.E.D., near Los Angeles International Airport (LAX) made headlines last week. The new shop will no doubt be a cultural hub in Los Angeles, offering top-shelf <a href="https://www.benzinga.com/markets/cannabis/24/07/39733952/snoop-dogg-to-open-weed-stores-in-la-amsterdam-named-after-iconic-smoke-weed-every-day-motto">premium products and services.</a>
<h3 class="wp-block-heading">Michigan's Market Is Thriving</h3>
Meanwhile, Michigan&#8217;s cannabis market is indisputably thriving marked by <a href="https://www.benzinga.com/markets/cannabis/24/07/39758729/cannabis-concentrates-brands-with-strong-growth-acquisition-targets-amid-industry-consolidation">high-growth brands</a> and a robust market structure, as highlighted by Benzinga's <a href="https://www.benzinga.com/author/nicol-s-jose-rodriguez">Nicolás Jose Rodriguez</a> in a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39828818/michigans-cannabis-market-hits-837m-record-whats-driving-the-boom-in-the-midwest">recap</a> of a report by Beacon Securities.
That report praised the performance of notable public companies in Michigan, including Ascend Wellness Holdings, Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/AAWH#CSE">AAWH</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/AAWH#OTCQX">AAWH</a>), Grown Rogue International Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/GRIN#CSE">GRIN</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GRUSF#OTC">GRUSF</a>), TerrAscend Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TSNDF#OTC">TSNDF</a>) and Red White &amp; Bloom Brands Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/RWB#CSE">RWB</a>) while a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38282615/cannabis-brands-leading-market-expansion-in-east-midwest-a-look-at-prices-and-trend">cannabis sector analysis</a> by Pablo Zuanic of Zuanic &amp; Associates underscored that the state&#8217;s market is highly fragmented, with Cresco&#8217;s High Supply and Ascend Wellness&#8217;s Ozone leading various segments, including the flower category.
Nevertheless, new data from <a href="https://www.benzinga.com/markets/cannabis/24/03/37521749/unpacking-the-58b-cannabis-market-boom-bdsa-forecasts-for-2028">cannabis analytics</a> firm BDSA revealed Michigan has emerged as the top seller of legal cannabis in the U.S., surpassing the Golden State in unit sales. Michigan sold 22 million cannabis products in March, compared to 21.3 million units sold in California over the same month. That milestone was the first time another state has outsold <a href="https://www.benzinga.com/markets/cannabis/24/06/39207863/michigan-beats-california-in-legal-cannabis-sales-why-is-golden-states-weed-industry-losing-its-">California in legal cannabis products.</a> Another milestone is a per capita sales of 21+ population of $233.97 in Michigan compared to $74.90 in California.
Yet marijuana sales in Michigan on <a href="https://www.benzinga.com/markets/cannabis/24/07/39820832/michigan-top-seller-of-legal-cannabis-in-us-reports-flat-sales-in-june-colorados-marijuana-downt">a monthly basis</a> have been flat over the past couple of months with June figures of $278.8 million, representing a 6.9% year-over-year growth or &#8220;the slowest annual growth in over two years,&#8221; <a href="https://www.newcannabisventures.com/michigan-cannabis-sales-slow/">according</a> to New Cannabis Venture&#8217;s Alan Brochstein.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/23/03/31357863/shop-legal-weed-at-michigans-top-rated-cannabis-dispensaries-here-are-the-shops-made-the-list">Shop Legal Weed At Michigan&#8217;s Top Rated Cannabis Dispensaries, Here Are The Shops Made The List</a>
<h3 class="wp-block-heading">Remaining Top 3</h3>
As Green Market Report's compilation of sales data showed, Illinois with its roughly $851 million figure in legal marijuana sales for the first half of 2024 came third. Combined with medical sales, the total cannabis sales figure reached $1 billion as <a href="https://www.benzinga.com/markets/cannabis/24/07/39731191/illinois-2024-cannabis-sales-reach-1b-milestone-faster-than-expected-are-out-of-state-consumers-">recently reported by Gov. JB Pritzker‘s office.</a>
Illinois will welcome a slew of top cannabis entrepreneurs, experts and executives at this fall&#8217;s Benzinga Cannabis Capital Conference in Chicago on Oct. 8-9. <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">Get your tickets now</a> before prices surge by following <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">this link</a>.
Massachusetts and Missouri followed with $795 million and $709 million, respectively, in recreational cannabis sales reported in the first six months of 2024.
Massachusetts Cannabis Control Commission's (CCC) recent data showed that combined medical and cannabis sales dipped <a href="https://www.benzinga.com/markets/cannabis/24/07/39670141/massachusetts-cannabis-sales-decline-slightly-in-june-despite-annual-quarterly-growth">slightly in June</a>, marking a 2% month-over-month decrease from $155 million in May to $152 million. Some of the major players doing business in the nascent market are AYR Wellness Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AYRWF#OTC">AYRWF</a>), The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CBSTF#OTCQX">CBSTF</a>) (FSE: 3LP), Curaleaf International (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>), Cresco Labs Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#CSE">CL</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTCQX">CRLBF</a>) (FSE: 6CQ) and Green Thumb Industries Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>).
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/04/38261253/missouris-2b-marijuana-market-hits-record-sales-in-march-eyes-future-growth-with-microbusiness-l">Missouri&#8217;s $2B Marijuana Market Hits Record Sales In March, Eyes Future Growth With Microbusiness Licenses </a></li>
</ul>

Retail Sales

AAWH

AYRWF

THE CANNABIST CO HLDG by THE CANNABIST COMPANY HOLDINGS INC.

CBSTF

CRLBF

CSE:AAWH

CSE:CL

CSE:GRIN

CSE:RWB

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

GRUSF

GTBIF

TSNDF

Cannabis Is Flying Off The Shelves In These Five States, Earning Billions For Marijuana Companies

Wells Fargo analyst Hanwen Chang maintains Vital Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTLE#NYSE">VTLE</a>) with a Equal-Weight and lowers the price target from $54 to $50.

VTLE

Wells Fargo Maintains Equal-Weight on Vital Energy, Lowers Price Target to $50

In a surprising turn of events, Chinese social media users and former President Donald Trump have come to a shared conclusion: Vice President Kamala Harris has a slim chance of winning the upcoming November elections.
What Happened: Chinese social media platform Weibo is buzzing with discussions suggesting that Trump&#8217;s victory is a foregone conclusion. This sentiment has been fueled by a failed assassination attempt on Trump, Business Insider <a href="https://www.businessinsider.in/politics/world/news/china-finally-agrees-with-trump-on-something-they-both-think-kamala-harris-cant-win/articleshow/111918971.cms">reported</a> on Monday.
President Joe Biden&#8216;s decision to step down from the election race has gone viral in China, with online consensus leaning towards Trump&#8217;s campaign rhetoric. Initial reactions from Chinese commentators have dismissed Harris, endorsed by Biden as the Democratic nomination, as having an even lower chance of winning the White House than Biden himself.
Trump, now the official Republican nominee, echoed this sentiment on Sunday, stating that Harris would be &#8220;easier to beat than Joe Biden would have been.&#8221;
See Also: <a href="https://www.benzinga.com/news/24/07/39877062/nvidia-reportedly-developing-a-new-version-of-its-flagship-ai-chip-for-chinese-market-amid-us-export?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Nvidia Reportedly Developing A New Version Of Its Flagship AI Chip For Chinese Market Amid US Export Rest</a>
While China&#8217;s heavily moderated social media is not a true indicator of its foreign policy, these discussions provide insight into the rhetoric the authorities allow to thrive. 
&#8220;Trump has basically secured the presidency, there&#8217;s no need for others to continue the act. It&#8217;s awkward and not even entertaining,&#8221; wrote one blogger based in Gansu.
&#8220;The Democratic Party&#8217;s chaotic replacement of generals is like the medicine of Wu Dalang,&#8221;&nbsp;another blogger wrote, referring to a famous Chinese tale of a man who survived poisoning but was still suffocated to death by his wife. 
&#8220;You will die whether you take it or not.&#8221;
Why It Matters: Despite the predictions from Trump and China, a FiveThirtyEight round-up of the latest polls shows that Harris&#8217; <a href="https://fivethirtyeight.com/">performance with voters </a>differs from Biden&#8217;s by only a small margin — typically by one or two percentage points at most. At times, she fares better than the president.
However, the relationship between China and the U.S. could <a href="https://www.benzinga.com/news/24/05/39036025/second-trump-term-could-lead-to-confrontational-relationship-between-china-us-says-expert-likely-exp">face new challenges </a>if Trump wins the upcoming U.S. presidential election, according to a Chinese expert. Jia Qingguo, a professor at Peking University, warned of increased confrontations if Trump is re-elected.
Furthermore, the U.S. Ambassador to China, Nicholas Burns, has leveled serious accusations against Beijing, stating that it is actively <a href="https://www.benzinga.com/news/24/06/39481245/us-envoy-slams-china-for-undermining-diplomatic-relations-taking-dramatic-steps-to-make-it-impossibl">sabotaging diplomatic relations </a>between the two nations.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39858529/amid-russia-china-tensions-us-bolsters-defenses-with-new-satellite-jammers-that-can-responsibly-coun?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Amid Russia-China Tensions, US Bolsters Defenses With New Satellite Jammers That Can &#8216;Responsibly Counter</a></li>
</ul>
Photo by Sheila Fitzgerald on Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Politics

General

Chinese Social Media Users Think Kamala Harris Can't Win Against Trump: 'It's Awkward And Not Even Entertaining'

Data from prediction market platform Polymarket indicates that bettors think former First Lady Michelle Obama may have a chance at becoming the Democratic nominee for <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39880291/president-bidens-exit-followed-nearly-80m-in-wagers-on-crypto-prediction-market-polymarket">the Presidential election</a>.
The <a href="https://polymarket.com/event/democratic-nominee-2024?tid=1721653988893">market</a>, which has attracted over $214 million in bets, gives Michelle Obama a 11% chance of replacing President Joe Biden as the nominee, making her the second favorite after Vice President Kamala Harris. $24 million have been traded on the prospects of the former First Lady alone.
The betting trend shows Obama&#8217;s chances more than tripling in the last 24 hours alone, from 3% to over 10%.
This uptick could be interpreted as a response to recent political developments, including President Joe Biden&#8216;s unexpected withdrawal from the race and his endorsement of Vice President Kamala Harris <a href="https://www.benzinga.com/news/24/07/39875181/trump-wants-republicans-reimbursed-after-biden-quits-we-have-to-start-all-over-again">as the Democratic nominee.</a>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39880421/bitcoin-dominates-ethereum-rebounds-heres-how-much-crypto-funds-raked-in-last-week#google_vignette">Bitcoin Dominates, Ethereum Rebounds: Here&#8217;s How Much Crypto Funds Raked In Last Week</a>
Entrepreneur and investor Balaji S. Srinivasan <a href="https://x.com/balajis/status/1815122771019731401">said</a>, &#8220;Obama is not endorsing Kamala. He&#8217;s calling for an open convention. Michelle Obama may be his nominee.&#8221; This statement, while not reflected in the current betting odds, has added fuel to ongoing discussions about potential shake-ups in the Democratic field.
Speculations about Michelle Obama have abounded, despite the former First Lady being on record <a href="https://www.axios.com/2024/06/27/michelle-obama-private-frustration-bidens-2024-election">saying</a> &#8220;you would be crazy to go into politics.&#8221;
Anastasija Plotnikova, CEO of Fideum told Benzinga that Donald Trump is currently favored to win the upcoming Presidential election, with 72% of bets in his favor in a separate market. That market has seen over $260 million in bets, dwarfing the volume in the Michelle Obama market.
What&#8217;s Next: For those seeking to delve deeper into the future of digital assets and their potential impact on various sectors, including politics, the upcoming Benzinga <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets </a>event on Nov. 19 promises to offer valuable insights.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39867522/trump-campaign-eyes-crypto-voters-what-vp-jd-vances-nomination-means-for-bitcoin">Trump Campaign Eyes Crypto Voters: What VP JD Vance&#8217;s Nomination Means For Bitcoin</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Michelle Obama For Democratic Nominee? Crypto Bettors Think Her Odds Have Just Tripled

Halliburton Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) reported worse-than-expected second-quarter <a href="https://www.benzinga.com/news/earnings/24/07/39858954/halliburtons-q2-revenue-miss-highlights-challenges-in-us-market-despite-international-gains">revenue results on Friday</a>.
Halliburton reported second-quarter 2024 revenue of $5.833 billion, missing the consensus of $5.949 billion. EPS of 80 cents was in line with the consensus, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Completion and Production revenue was $3.4 billion, flat Q/Q, while Drilling and Evaluation revenue came in at $2.4 billion, flat Q/Q.
International revenue was $3.4 billion, an increase of 3% Q/Q, with revenue from Latin America flat Q/Q, Europe/Africa +4% Q/Q, and Middle East/Asia +5% Q/Q.
Jeff Miller, Chairman, President, and CEO, said, "In our international markets we see strong demand for Halliburton's services, high activity levels, and equipment tightness across all major basins."
Halliburton shares fell 5.6% to close at $34.40 on Friday.
These analysts made changes to their price targets on Halliburton following the announcement.
<ul>
<li>Susquehanna analyst Charles Minervino maintained Halliburton with a Positive rating, while lowering the price target from $49 to $46.</li>
<li>Piper Sandler analyst Luke Lemoine maintained the stock with an Overweight rating and cut the price target from $46 to $40.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39881526/wall-streets-most-accurate-analysts-say-hold-these-3-utilities-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Say Hold These 3 Utilities Stocks With Over 5% Dividend Yields</a></li>
</ul>

Halliburton Analysts Lower Their Forecasts After Q3 Results

Alphabet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) is <a href="https://www.benzinga.com/markets/equities/24/07/39874391/tesla-alphabet-gm-ford-lead-earnings-parade-this-week-as-market-struggles-to-sustain-the-summer-">scheduled to release its second-quarter results</a> after the market close on Tuesday, and ahead of the release, a bullish analyst reiterated his positive stance. The Google parent is the first AI stalwart to report this earnings season and therefore, all eyes will be riveted on the report.
Analysts, on average, expect the company to report earnings of $1.85 per share compared to the year-ago&#8217;s $1.44, and revenue of $84.20 billion versus last year&#8217;s $74.60 billion.
The Alphabet Analyst: Wedbush analyst Scott Devitt reiterated an Outperform rating and $205 price target for the stock. 
The Alphabet Thesis: &#8220;The setup remains positive heading into 2Q results,&#8221; said Devitt, citing findings from the firm&#8217;s ad survey and agency commentary that pointed to continued strength for Google Search. The analyst said he raised his Google Search revenue growth estimate from 12% to 12.8% to $47.75 billion. Sequentially search revenue is now expected to see a more modest sequential deceleration in growth, he added.
The survey results have increased conviction in spending intent for the full year, the Wedbush analyst said.
See Also:<a href="https://www.benzinga.com/money/best-communication-services-stocks"> Best Communication Services Stocks</a>
Devitt expects operating income to exceed consensus estimates by about 2%. &#8220;With cost controls still in place, we expect continued operating margin expansion in 2Q,&#8221; he said, adding that operating margin will likely come in at 31.7% versus the 31.1% consensus estimate.
The analyst said the chances of seeing a negative surprise related to spending are relatively low in the second quarter as the increased capital intensity is better understood and estimates for depreciation &amp; amortization and capex have risen materially following guidance last quarter. 
Devitt said he would focus on the following:
<ul>
<li>operating expense and CapEx growth related to AI investments</li>
<li> 2H advertising growth as comps become more challenging</li>
<li>ongoing monetization of AI services within the cloud unit</li>
</ul>
Alphabet Price Action: Alphabet&#8217;s Class A shares listed on the Nasdaq rose 1.43% to $180.20 in premarket trading on Monday, according to <a href="https://benzinga.grsm.io/register174">Benzinga Pro data.</a> The stock is up over 27% for the year-to-date period.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39820669/google-parent-alphabets-q2-expected-to-shine-with-ai-youtube-shorts-cloud-strength-analyst">Google Parent Alphabet&#8217;s Q2 Expected To Shine With AI, YouTube Shorts, Cloud Strength: Analyst</a></li>
<li></li>
</ul>
Image Via Shutterstock

Analyst Color

Equities

Previews

Reiteration

Tech

GOOG

GOOGL

Alphabet Set To Report Strong Q2 Results With Increased Search Revenue: Analyst Bullish On Google Parent Flags 3 Things That Will Be On His Radar

Wells Fargo analyst Zachary Fadem maintains Tractor Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) with a Overweight and raises the price target from $285 to $295.

TSCO

Wells Fargo Maintains Overweight on Tractor Supply, Raises Price Target to $295

Wells Fargo analyst Ike Boruchow maintains Burlington Stores (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) with a Overweight and raises the price target from $275 to $300.

BURL

Wells Fargo Maintains Overweight on Burlington Stores, Raises Price Target to $300

<ul>
<li>NVDA</li>
<li>TSLA</li>
<li>CRWD</li>
<li>WAY</li>
<li>DJT</li>
<li>TSM</li>
<li>QQQ</li>
<li>AMD</li>
<li>LOT</li>
<li>AI</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

CRWD

TSLA

Top 10 Trending Stocks On WallStreetBets As Of July 22 2024 (Via Swaggy Stocks)

WIIM

Shares of Nvidia are trading higher following a report suggesting the company is preparing a version of its AI chips for the Chinese market. Additionally, Piper Sandler maintained an Overweight rating and raised its price target from $120 to $140.

Monday, Hepion Pharmaceuticals Inc (NASDAQ:&nbsp;HEPA) entered into a definitive merger agreement with Pharma Two B Ltd., a late-clinical stage private Israeli company developing P2B001, a combination product candidate in <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/g39880821/pharma-two-b-announces-plans-to-go-public-via-merger-with-hepion-pharmaceuticals-inc-and-concurren" rel="noreferrer noopener">development for Parkinson&#8217;s Disease</a>.
The merger is valued at an estimated pro-forma implied equity value of approximately $58.5 million.
Hepion will merge into and become an indirectly wholly-owned subsidiary of Pharma Two B.
The combined company will continue to operate under the &#8220;Pharma Two B&#8221; name. Pharma Two B has agreed to file a registration statement with the SEC to register the ordinary shares proposed to be issued to Hepion&#8217;s equity holders in the acquisition. It will also apply to list its ordinary shares on Nasdaq under the ticker symbol &#8220;PHTB.&#8221;
&#8220;P2B001 offers a novel, easy-to-use therapeutic approach, that is designed to address the unmet need for an effective, safe, once-daily, no titration required treatment with a lower incidence of excessive daytime sleepiness—a common side effect of currently available dopamine agonist treatments in Parkinson&#8217;s disease patients&#8221; said Dan Teleman, Chief Executive Officer of Pharma Two B.
&#8220;Our company is in a stage that we believe meets the public market and investors&#8217; expectations. We are excited about Pharma Two B&#8217;s next growth phase, moving P2B001 towards an NDA submission targeted for the first half of 2026 and making this potential treatment available to patients,&#8221; he continued.
Hepion has also announced a private placement of $2.9 million non-convertible senior notes to qualified institutional investors.
Pharma Two B has entered into a securities purchase agreement for an $11.5 million private placement of ordinary shares and accompanying Series A warrants and Series B warrants.
In April, Hepion Pharmaceuticals began wind-down activities in its ASCEND-NASH Trial while continuing to explore strategic alternatives, as previously <a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/g38342739/hepion-pharmaceuticals-initiates-wind-down-activities-in-phase-2b-ascend-nash-trial" rel="noreferrer noopener">announced in December 2023</a>.
Price Action: HEPA stock is up 1.96% at $1.04 during the premarket session at last check Monday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/07/39881151/johnson-johnson-faces-legal-hurdle-in-talc-lawsuit-battle" target="_blank" rel="noreferrer noopener">Johnson &amp; Johnson Faces Legal Hurdle In Talc Lawsuit Battle</a>.</li>
</ul>

Biotech

Health Care

HEPA

Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
<ul>
<li>Goldman Sachs cut the price target for Lennar Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) from $180 to $174. Goldman Sachs analyst Susan Maklari downgraded the stock from Buy to Neutral. Lennar shares gained 0.5% to close at $170.94 on Friday. <a href="https://www.benzinga.com/quote/LEN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler increased the price target for NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) from $120 to $140. Piper Sandler analyst Harsh Kumar maintained an Overweight rating. NVIDIA shares fell 2.6% to close at $117.93 on Friday. <a href="https://www.benzinga.com/quote/ITCI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wedbush cut the price target for Chuy&#8217;s Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHUY#NASDAQ">CHUY</a>) from $38 to $37.5. Wedbush analyst Nick Setyan downgraded the stock from Outperform to Neutral. Chuy&#8217;s shares fell 0.7% to close at $37.08 on Friday. <a href="https://www.benzinga.com/quote/CHUY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Truist Securities decreased Comerica Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) price target from $55 to $53. Truist Securities analyst Brandon King downgraded the stock from Buy to Hold. Comerica shares fell 10.5% to close at $50.42 on Friday. <a href="https://www.benzinga.com/quote/CMA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B. Riley Securities boosted the price target for Redwire Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) from $6 to $8. B. Riley Securities analyst Mike Crawford downgraded the stock from Buy to Neutral. Redwire shares fell 0.9% to close at $6.98 on Friday. <a href="https://www.benzinga.com/quote/RDW/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel raised International Flavors &amp; Fragrances Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) price target from $95 to $115. Stifel analyst Mark Astrachan upgraded the stock from Hold to Buy. International Flavors shares fell 1% to close at $95.67 on Friday. <a href="https://www.benzinga.com/quote/IFF/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird raised Henry Schein, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSIC#NASDAQ">HSIC</a>) price target from $81 to $92. Baird analyst Jeff Johnson upgraded the stock from Neutral to Outperform. Henry Schein shares fell 0.5% to close at $70.34 on Friday. <a href="https://www.benzinga.com/quote/HSIC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley cut Alaska Air Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) price target from $75 to $70. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. Alaska Air shares gained 1.8% to close at $37.93 on Friday. <a href="https://www.benzinga.com/quote/ALK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank cut Domino&#8217;s Pizza, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) price target from $580 to $500. Deutsche Bank analyst Lauren Silberman maintained a Buy rating. Domino&#8217;s shares fell 1.2% to close at $404.17 on Friday. <a href="https://www.benzinga.com/quote/DPZ/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan increased Abercrombie &amp; Fitch Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) price target from $167 to $194. JP Morgan analyst Matthew Boss upgraded the stock from Neutral to Overweight. Abercrombie &amp; Fitch shares gained 1% to close at $158.51 on Friday. <a href="https://www.benzinga.com/quote/ANF/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39876945/s-p-500-logs-worst-weekly-decline-since-april-investor-optimism-falls-further">S&amp;P 500 Logs Worst Weekly Decline Since April; Investor Optimism Falls Further</a></li>
</ul>

CHUY

HSIC

ITCI

NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday

Piper Sandler analyst Scott Siefers maintains Huntington Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) with a Underweight and raises the price target from $11.5 to $13.5.

HBAN

Piper Sandler Maintains Underweight on Huntington Bancshares, Raises Price Target to $13.5

Barclays analyst Jared Shaw maintains Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) with a Overweight and raises the price target from $86 to $92.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

The Advisors' Inner Circle Fund III Strategas Macro Thematic Opportunities ETF

News

Latest news for The Advisors' Inner Circle Fund III Strategas Macro Thematic Opportunities ETF (ARCA:SAMT)